Improved Identification of High-Risk Cancer Patients using RNA Analysis Supporting Patients with Better Variant Classification

  • When genetic test results for your patients come back with variants of unknown significance, how do you truly determine hereditary cancer risk and provide medical management recommendations? What if there’s a solution for DNA testing’s limited interpretations?

    In this webinar, we share our experience pairing DNA and RNA sequencing to yield more accurate results. We’ll include an in-depth look at several cases to illustrate the potential benefit to individuals and their families.

    Questions We'll Answer:

    • How is RNA evidence interpreted and applied toward variant classification?
    • How does improved test accuracy translate to clinical significance for high-risk cancer patients? (Presented with case examples!)


    Carrie Horton, MS, CGC
    Sr. Clinical Researcher Specialist 

    Terra Brannan, PhD
    Variant Assessment Scientist

    Jessica Grzybowski, MS, CGC
    Lead Genetic Counselor


  • Tue, November 16, 2021
  • 9:00am PST
  • Duration: 45 minutes
  • C.E.U. --
  • P.A.C.E. --

Upcoming Webinars

Subscribe to receive notifications for future webinars.

Search Results

Start your search...